328 related articles for article (PubMed ID: 14638686)
41. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
42. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease.
Choi HY; Karten B; Chan T; Vance JE; Greer WL; Heidenreich RA; Garver WS; Francis GA
J Biol Chem; 2003 Aug; 278(35):32569-77. PubMed ID: 12813037
[TBL] [Abstract][Full Text] [Related]
43. Trafficking defects in endogenously synthesized cholesterol in fibroblasts, macrophages, hepatocytes, and glial cells from Niemann-Pick type C1 mice.
Reid PC; Sugii S; Chang TY
J Lipid Res; 2003 May; 44(5):1010-9. PubMed ID: 12611909
[TBL] [Abstract][Full Text] [Related]
44. Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages.
Namatame I; Tomoda H; Ishibashi S; Omura S
Proc Natl Acad Sci U S A; 2004 Jan; 101(3):737-42. PubMed ID: 14718664
[TBL] [Abstract][Full Text] [Related]
45. A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels.
Ikenoya M; Yoshinaka Y; Kobayashi H; Kawamine K; Shibuya K; Sato F; Sawanobori K; Watanabe T; Miyazaki A
Atherosclerosis; 2007 Apr; 191(2):290-7. PubMed ID: 16820149
[TBL] [Abstract][Full Text] [Related]
46. Exposure of macrophages to PLA2-modified lipoproteins leads to cellular lipid accumulations.
Menschikowski M; Lattke P; Bergmann S; Jaross W
Anal Cell Pathol; 1995 Sep; 9(2):113-21. PubMed ID: 7492515
[TBL] [Abstract][Full Text] [Related]
47. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and high-density lipoprotein-induced cholesterol efflux in macrophages.
Azuma Y; Kawasaki T; Ikemoto K; Ohno K; Yamada T; Yamasaki M; Nobuhara Y
Jpn J Pharmacol; 1999 Feb; 79(2):159-67. PubMed ID: 10202851
[TBL] [Abstract][Full Text] [Related]
48. The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells.
Wojtanik KM; Liscum L
J Biol Chem; 2003 Apr; 278(17):14850-6. PubMed ID: 12591922
[TBL] [Abstract][Full Text] [Related]
49. Decreased arachidonate metabolism in mouse peritoneal macrophages after foam cell transformation with oxidized low-density lipoproteins.
Arai H; Nagano Y; Narumiya S; Kita T
J Biochem; 1992 Oct; 112(4):482-7. PubMed ID: 1491002
[TBL] [Abstract][Full Text] [Related]
50. Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism.
Schmitz G; Robenek H; Beuck M; Krause R; Schurek A; Niemann R
Arteriosclerosis; 1988; 8(1):46-56. PubMed ID: 2829803
[TBL] [Abstract][Full Text] [Related]
51. Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells.
Abi-Mosleh L; Infante RE; Radhakrishnan A; Goldstein JL; Brown MS
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19316-21. PubMed ID: 19884502
[TBL] [Abstract][Full Text] [Related]
52. Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells: reduced arachidonate release with concomitant decrease in cyclooxygenase products.
Pomerantz KB; Hajjar DP
J Lipid Res; 1989 Aug; 30(8):1219-31. PubMed ID: 2504863
[TBL] [Abstract][Full Text] [Related]
53. Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells.
Cui D; Thorp E; Li Y; Wang N; Yvan-Charvet L; Tall AR; Tabas I
J Leukoc Biol; 2007 Nov; 82(5):1040-50. PubMed ID: 17576822
[TBL] [Abstract][Full Text] [Related]
54. Translocation of phospholipase A2 to membranes by oxidized LDL and hydroxyoctadecadienoic acid to contribute to cholesteryl ester formation.
Akiba S; Ii H; Yoneda Y; Sato T
Biochim Biophys Acta; 2004 Nov; 1686(1-2):77-84. PubMed ID: 15522824
[TBL] [Abstract][Full Text] [Related]
55. Acyl-CoA binding protein (ACBP) regulates acyl-CoA:cholesterol acyltransferase (ACAT) in human mononuclear phagocytes.
Kerkhoff C; Beuck M; Threige-Rasmussen J; Spener F; Knudsen J; Schmitz G
Biochim Biophys Acta; 1997 Jun; 1346(2):163-72. PubMed ID: 9219899
[TBL] [Abstract][Full Text] [Related]
56. Physiological and coordinate downregulation of the NPC1 and NPC2 genes are associated with the sequestration of LDL-derived cholesterol within endocytic compartments.
Jelinek D; Patrick SM; Kitt KN; Chan T; Francis GA; Garver WS
J Cell Biochem; 2009 Dec; 108(5):1102-16. PubMed ID: 19746448
[TBL] [Abstract][Full Text] [Related]
57. Oleate and other long chain fatty acids stimulate low density lipoprotein receptor activity by enhancing acyl coenzyme A:cholesterol acyltransferase activity and altering intracellular regulatory cholesterol pools in cultured cells.
Rumsey SC; Galeano NF; Lipschitz B; Deckelbaum RJ
J Biol Chem; 1995 Apr; 270(17):10008-16. PubMed ID: 7730302
[TBL] [Abstract][Full Text] [Related]
58. Lack of requirement for sterol carrier protein-2 in the intracellular trafficking of lysosomal cholesterol.
Johnson WJ; Reinhart MP
J Lipid Res; 1994 Apr; 35(4):563-73. PubMed ID: 8006511
[TBL] [Abstract][Full Text] [Related]
59. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity.
Feng B; Tabas I
J Biol Chem; 2002 Nov; 277(45):43271-80. PubMed ID: 12215451
[TBL] [Abstract][Full Text] [Related]
60. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
